Skin Diseases, Infectious
27
0
0
24
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
12 trials with published results (44%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
7.4%
2 terminated out of 27 trials
92.3%
+5.8% vs benchmark
59%
16 trials in Phase 3/4
50%
12 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (27)
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
Cantharidin and Occlusion in Verruca Epithelium
Effect of an Antiseptic Solution on the Skin Microbiome
Dalbavancin in Real Clinical Practice in Spain
Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)
Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Skin and Soft Tissue Infection (SSTI) Study
Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management
Effect of Chlorhexidine Skin Cleansing on Skin Flora
Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections
MRSA Colonization and Control in the Dallas County Jail
Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections
AUGMENTIN 1gm In Skin And Soft Tissue Infection
Effective Antibiotic Treatment of MRSA
Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age